Henry Schein, Inc., one of North America’s largest healthcare solutions distributors, has appointed Frederick M. Lowery as its new Chief Executive Officer, effective March 2, at which time he will join the Board of Directors. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board. Henry Schein announced this past July that Bergman would step down at the end of 2025.

Lowery brings more than two decades of healthcare expertise to Henry Schein. Most recently, he served as Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific, leading the Fisher Scientific distribution channel’s above-market performance. In a news release, the company stated his experience growing distribution and owned product businesses – including manufacturing, R&D, marketing, and sales functions – closely aligns with Henry Schein’s business model, positioning him to guide the company’s next phase of growth and continued execution of its BOLD+1 strategic plan.

“I am honored to join Henry Schein at such a pivotal moment. This is an organization with immense potential to impact clinicians and patients, given its remarkable reputation for innovation, customer service, and partnership,” Lowery said. “I look forward to working with Team Schein to build on the strong foundation established by Stan while accelerating value creation.”

Prior to joining Thermo Fisher, Lowery worked in leadership roles for Maytag Corporation and General Motors. He holds a master’s degree in manufacturing management from Kettering University (formerly General Motors Institute of Engineering and Management) and a bachelor’s degree in mechanical engineering from Tennessee Technological University.

“I am very pleased to welcome Fred to Henry Schein. Beyond his extensive operational experience, he brings a leadership philosophy that reflects the values that have long defined our company,” Bergman added. “Fred understands the critical role we play in supporting dental and medical practitioners, and he is exceptionally well equipped to lead Henry Schein into its next phase of growth.”